Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Select Medical Holdings (SEM) Long-Term Debt Issuances (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Long-Term Debt Issuances for 7 consecutive years, with -$21.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Long-Term Debt Issuances fell 102.61% to -$21.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $339.9 million, a 59.38% decrease, with the full-year FY2024 number at $1.2 billion, changed N/A from a year prior.
  • Long-Term Debt Issuances was -$21.4 million for Q3 2025 at Select Medical Holdings, down from $5.3 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $819.0 million in Q3 2024 to a low of -$22.3 million in Q3 2023.
  • A 5-year average of $80.6 million and a median of $10.6 million in 2021 define the central range for Long-Term Debt Issuances.
  • Peak YoY movement for Long-Term Debt Issuances: tumbled 265.04% in 2022, then skyrocketed 3772.84% in 2024.
  • Select Medical Holdings' Long-Term Debt Issuances stood at $13.5 million in 2021, then plummeted by 229.6% to -$17.5 million in 2022, then decreased by 27.46% to -$22.3 million in 2023, then surged by 1624.36% to $339.9 million in 2024, then tumbled by 106.28% to -$21.4 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Long-Term Debt Issuances are -$21.4 million (Q3 2025), $5.3 million (Q2 2025), and $16.0 million (Q1 2025).